Disclaimers. Smoking and Smoking Cessation. Worldwide. Objectives. Statistics at Home. Smoking Epidemic 16/10/2017

Size: px
Start display at page:

Download "Disclaimers. Smoking and Smoking Cessation. Worldwide. Objectives. Statistics at Home. Smoking Epidemic 16/10/2017"

Transcription

1 Disclaimers Smoking and Smoking Cessation Dr. Janneke Gradstein CCFP(EM) Yarmouth, NS Received CHA Funding 6 th Annual Ottawa Conference: State of the Art Clinical Approaches to smoking cessation. References Disease Interrupted: Tobacco Reduction and Cessation by Els et al The Ottawa Model for Smoking Cessation (workshop materials) The Tobacco Atlas 4 th edition by Eriksen et al Canadian Action Network for the Advancement, Dissemination and Adoption of Practice-informed Tobacco Treatment (CAN-ADAPTT) Free-NS-Strategy.pdf Objectives Where smoking has been and where it s going Money and profit in industry and government HOW TO HELP PEOPLE QUIT! Worldwide 1 billion male smokers 250 million female smokers Rates overall decreasing in richer nations Rates climbing rapidly in poorer nations Smoking Epidemic Develops over 100 years Staggered start times Wealthier nations got a head start Stages I - IV Statistics at Home Canada, 2012 Smokers over age 15: 16% Smoked in pregnancy ages 25-44: 4.8% Smoked in pregnancy ages 20-24: 22.8% In Nova Scotia, 2011 Smoked in pregnancy (all ages): 21.3% 1

2 Economic Analysis: USA Value of cigarette sales: 71 billion$ per year Total cost of smoking: 193 billion$ per year Economic Analysis: Nova Scotia Government tobacco revenue (2011): $213.1 million / year Health Care costs: Direct: $170 million/ year Indirect: $760 million / year Total Government cost $950 million/year Source: Health Impact World Health Organization: Tobacco is the leading cause of preventable death and disease worldwide. Quitting Smoking and Life Expectancy Added life expectancy with smoking cessation: Age 35 8 years Age 65 2 years Health Canada: Tobacco smoking is the single most preventable cause of disease, disability and premature death in Canada. Am J Public Health. 2002;92: (Cancer Prevention Study II, American Census Data 1990) Smoking and Post-op Complications Post-op wound infection 12% in smokers 2% in never smokers (p<0.05) Ann Surg. Jul 2003; 238(1): 1 5 Smoking cessation pre-operatively lowers surgical complications by 41% Am J of Medicine 2011; 124(2): Smoking and Post-op Complications Odds ratios for major surgical complications in smokers 30 Day Mortality: 1.3 ( ) Myocardial infarction: 2.09 ( Cardiac Arrest: 1.87 ( ) Stroke: 1.53 ( ) Pneumonia: 1.8 ( ) Anesthesiology 2011;114(4):

3 Addiction to Tobacco Addiction to Tobacco Addiction means continued smoking IN SPITE of knowing the harm! There are degrees of addiction AND dependence 50% of Canadian smokers tried to quit last year. 2/3 of those who tried to quit, tried more than once Addiction to Tobacco Approximately 60% of all Canadian smokers intend to quit in the NEXT 6 MONTHS. Addiction to Tobacco Approximately 25% of all Canadian smokers intend to quit THIS MONTH. What can you do? The single, most powerful, preventative intervention in clinical practice. Woolf SH. JAMA 1999; 282(24): What can you do? 1. Influence public policy 2. Counsel patients to quit Inpatients Clinic patients ER patients OB patients Surgical patients 3. Prescribe pharmacotherapy 3

4 Public policy and smoking cessation What constitutes counselling? LIMITING ADVERTISMENTS PRODUCT LABELLING BAN PRODUCT PLACEMENT SMOKE-FREE ZONES TAXATION PUBLIC EDUCATION MENTION the role of smoking in their health ASK I know it s so challenging, but if there s anything I can do to help OFFER pharmacotherapy INFORM people about programming: addictions services, pharmacies, smokershelpline, ONLINE, APPS! Explore quitting history and help make plans What constitutes counselling Don t forget maintenance counselling!! - follow up after quit - consider checking in (get staff to call?) - make a stressful event kit Quit rates - Impact of Counselling MOST people quit unassisted. BUT 6-12 month quit rates for physician advice <3 minutes: OR 1.3 ( ) 3-10 minutes: OR 1.6 ( ) >10 minutes: OR 2.3 ( ) Fiore MC, Jaen CR, Baker TB, Bailey, WC, Benowitz, NL, Curry, SJ, et al. treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville MD: U.S. Department of Health and Human Services. Quit Rates Impact of Pharmacotherapy Nicotine Replacement Therapy vs Placebo OR 1.6 Combined NRT vs Placebo OR 3.0 Cochrane Database Syst rev; 2008 Bupropion vs Placebo OR RCTs of combined 8000 patients Varenicline vs Placebo OR 3.0 JAMA. 2006; 296(1): Quit Rates: Readiness to Quit Helps but is NOT necessary for long-term success! Can change at a moment s notice For example: hospitalization doc: When did you quit smoking? patient: Today 4

5 Hospital Policy: The Ottawa Model Inpatient smoking cessation programs 6 month smoking abstinence Control group: 18.3% Intervention group: 29.4% OR 1.71 ( P=0.02) Nicotine Tob Res Jan; 12(1): 11-8 Hospital Policy: The Ottawa Model 1. Identification of smoking status 2. Bedside counselling (RT or RN) 3. Pharmacotherapy Nicotine withdrawal order set Smoking cessation order set 4. Automated Follow-up 5. Follow-up counselling Hospital Policy: The Ottawa Model Readmission (all cause): 30 days 13.3% 7.1% ARR 6.1% (CI 2.9% to 9.3% p<0.001) 2 years % ARR 11.6% (CI 6.5% to 16.8% p<0.001) Mortality (all cause): 2 years 15.1% 7.9% ARR 7.3% (CI 3.9% to 10.7% p<0.001) Mullen KA, Manuel DG, Hawken SJ, et al Effectiveness of a hospital-initiated smoking cessation programme: 2-year health and healthcare outcomes Tobacco Control 2017;26: Pharmacotherapy Nicotine patch Nicotine gum Nicotine lozenge Nicotine inhaler Nicotine mouth spray Bupropion (SR) (Zyban) Varenicline (Champix) Degree of Nicotine Dependence Influences likelihood of successful quit Informs intensity of intervention Changes type and amount of pharmacotherapy Can be measured with the Fagerström Test for Nicotine Dependence Fagerström Test for Nicotine Dependence 1. How many cigarettes per day do you usually smoke? 2. How soon after you wake do you smoke your first cigarette? <5 min 6-30 min >30 min 3. Do you find it difficult to stop smoking in non-smoking areas? 4. Which cigarette would you hate most to give up? The first 1 of the morning Other 5. Do you smoke more frequently in the first hours after waking up than during the rest of the day? 6. Does your smoking make you so ill that you are in bed most of the day? 5

6 Fagerström Test for Nicotine Dependence 1. How many cigarettes per day do you usually smoke? 2. How soon after you wake do you smoke your first cigarette? <5 min 6-30 min >30 min 3. Do you find it difficult to stop smoking in non-smoking areas? 4. Which cigarette would you hate most to give up? The first 1 of the morning Other 5. Do you smoker more frequently in the first hours after waking up than during the rest of the day? 6. Does your smoking make you so ill that you are in bed most of the day? Nicotine Replacement Therapy slower onset than cigarettes More stable plasma levels of nicotine 50% lower blood nicotine levels than smoking. Nicotine Replacement Therapy Concurrent smoking NOT contraindicated! Addiction potential is mild Much safer than smoking in cardiovascular diseases pulmonary diseases Pregnancy NOT a carcinogen Physiological effects on vital signs and perfusion significantly less than those of withdrawal Nicotine Patch 16 or 24 hour delivery formats Benefit of 16 hour format: less insomnia Benefit of 24 hour format: morning cravings Nicotine Patch Traditionally 1ppd: use 21mg patches for 6 weeks, 14mg patches for 2 weeks, 7mg patches for 2 weeks Reality do whatever works for you (multiple patches, longer courses) If relapse occurs, continue or resume the patch Nicotine Patch Onset slow, time to maximal effect 6 hours Dosing <10 cigarettes = 7mg = 14mg >20 = 21mg >30 = 21mg + 7mg > 40 = 21mg + 21mg A pack of cigarettes is 20 or 25 cigarettes 6

7 Nicotine Patch Nicotine Patch Dose titration If usually smokes <30 min from waking, add 7mg If cravings are still high Add a short acting NRT Increase patch by 7mg increments Side effects: itching, burning, insomnia, chest pain and arrhythmias, dyspepsia Cost: approximately 25$ for 7 patches, any strength (ie $100 a month) Nicotine Gum Dosing 2 and 4mg strengths available Use 4mg if smoke <30min after waking pieces/day After 6 weeks taper (or not) Onset of action: 30 minutes Nicotine Gum Technique matters! Chew 1-2x then park 1 minute 1 piece lasts 30 minutes Chew every 1-2 hours NOT EFFECTIVE IN ACIDIC ENVIRONOMENT No food or drink 30 minutes before Won t work if swallowed Nicotine Gum Side effects: light-headedness, nausea, chest pain, arrhythmias Caution: Dentures and fillings, TMJ dysfunction Cost: approximately 40$ for 105 (120$ a month for 10 a day) Nicotine lozenge/pastilles Side effects: light-headedness, nausea, chest pain, arrhythmias OK for dentures or TMJ dysfunction Technique: Allow to dissolve slowly and switch sides NOT EFFECTIVE IN ACIDIC ENVIRONOMENT No food or drink 30 minutes before Won t work if swallowed 7

8 Nicotine lozenge/pastilles Dosing 1,2 and 4mg lozenges Use 1-2 lozenges 8-15 times per day use for 6 months then taper (or not) Onset 30 minutes Cost: 40$ for 88 (136$ per month for 10 a day) Nicotine Inhaler Does NOT work below 10 degrees celcius absorbed through the oral mucosa Onset 30 minutes 6-12 cartridges a day (4mg/cartridge) Nicotine Inhaler Side Effects: headache, nausea, burning, tingling of mouth, chest pain, arrhythmias, salivation, dyspepsia Technique works better if rinse mouth first Place mouthpiece in mouth and inhale deeply Inhale multiple times over 5-20 minutes Nicotine Inhaler Dosing 20 inhalations = 1mg nicotine = 1 cigarette Usually 6-12 cartridges are used per day for 3 months, then reduced gradually (or not) Cost 11$ for 6 cartridges (330$ a month for 6/day) Nicotine Mouth Spray Absorbed via oral mucosa Onset 10 minutes (or sooner) Dose: 1 spray = 1mg nicotine = 1 cigarette (good for impatient people) Cost: 42$ per bottle (150 sprays) Nicotine Mouth Spray Technique Spray into mouth Avoid inhaling Avoid swallowing for a few seconds after spray Technique works better if rinse mouth first Place mouthpiece in mouth and inhale deeply Inhale multiple times over 5-20 minutes 8

9 Nicotine Inhaler and Mouth Spray hand-mouth habit? Bupropion SR Synthesized in 1968 oldest smoking cessation drug we have. Mechanism of action Unknown Low abuse potential? Bupropion SR Positive side effects: less weight gain, less depression Negative side effects: insomnia,headache, dry mouth, nausea, anxiety, rash risk of seizures 1:1000 Contraindicated if risk factors for seizure! Bupropion SR Interactions Inhibits CYP 450 (2B6) Check CNS and cardiac drugs Metabolism potentiated by anticonvulsants Metabolism slowed by antiretrovirals Bupropion SR Varenicline Dosing: Bupropion SR 150mg OD x3d then BID x 12 weeks Consider extending up to 12 months Quit 8 days later Coverage: may be covered as Bupropion SR Cost: $28/month as Buproprion Entered human clinical trials in 1999 partial agonist of the α 4 β 2 nicotinic acetylcholine receptor mesolimbic system Agonist effect in brain BUT blocks the effects of nicotine in the brain Does NOT block the effects of nicotine on the rest of the body 9

10 Varenicline Minimal drug interactions Side effects Nausea Insomnia Abnormal dreams Neuropsychiatric events - no Cardiovascular events no Needs to be taken with food Dosing: Varenicline Usual 0.5mg OD x 3 days, then 0.5mg BID x 4 days, then 1.0mg BID x 12+ weeks Start 8 35 days before quit date Titrate! Varenicline Cost 1 month supply $ Half strength $ week supply $360 A word about caffeine Smoking potentiates caffeine metabolism After cessation caffeine levels may double or triple! Caffeine toxicity mimics and worsens cravings NRT does not prevent this! A word about e-cigarettes Not regulated Produced by the tobacco industry Proceed with caution Population health impact Gateway to smoking Teen smoking initiation RE-Normalization of smoking after HUGE antismoking public health efforts Surgical patients Cardiac patients Obstetrical patients Psychiatric patients Special populations 10

11 Thank you! 11

Smoking Cessation: Treating Tobacco Dependence

Smoking Cessation: Treating Tobacco Dependence Smoking Cessation: Treating Tobacco Dependence Pat Folan, RN Center for Tobacco Control Pulmonary Medicine NS-LIJ Health System NYS DOH Tobacco Control Program Treating Tobacco Dependence Center for Tobacco

More information

Tobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing

Tobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing GOAL To build the capacity of prescribing clinicians in behavioral health settings to integrate best practices for prescribing

More information

Pharmacotherapy Summary for the Treatment of Nicotine Withdrawal and Nicotine Dependence 1

Pharmacotherapy Summary for the Treatment of Nicotine Withdrawal and Nicotine Dependence 1 Pharmacotherapy Summary for the Treatment of Nicotine Withdrawal and Nicotine Dependence 1 Compiled by: TOP, in collaboration with Dr. Charl Els and Mr. Ron Pohar: TRaC II (Alberta Medical Association/Primary

More information

SMOKING CESSATION WORKSHOP. Dr Mark Palayew December

SMOKING CESSATION WORKSHOP. Dr Mark Palayew December SMOKING CESSATION WORKSHOP Dr Mark Palayew December 5 2016 Conflicts of Interest None Case 1 Mr. T is a 55 year old smoker 2 packs/day He has been smoking continuously since age 16 When he wakes up at

More information

An Evolving Perspective on Smoking Cessation Therapies

An Evolving Perspective on Smoking Cessation Therapies An Evolving Perspective on Smoking Cessation Therapies Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe,

More information

Pharmacologic Therapy for Tobacco Use & Dependence

Pharmacologic Therapy for Tobacco Use & Dependence Pharmacologic Therapy for Tobacco Use & Dependence Thomas Gauvin, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1 Learning Objectives Understand the 7 first line medications

More information

My Mask. I keep it all inside. Because I d rather. The pain destroy me. Than everyone else. Anon.

My Mask. I keep it all inside. Because I d rather. The pain destroy me. Than everyone else. Anon. My Mask KL I keep it all inside Because I d rather The pain destroy me Than everyone else. Anon. 43 K. N. Roy Chengappa, M.D., FRCPC Professor of Psychiatry, University of Pittsburgh School of Medicine,

More information

Best Practice for Smoking Cessation: Pharmacotherapy. Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree

Best Practice for Smoking Cessation: Pharmacotherapy. Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree Best Practice for Smoking Cessation: Pharmacotherapy Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree Why is it so hard to quit? People who smoke aren t weak

More information

Smoking Cessation. Disclosures. Thank You. None

Smoking Cessation. Disclosures. Thank You. None Smoking Cessation Dr. Jamie Kellar; BSc, BScPhm, PharmD Clinician Educator Centre for Addiction and Mental Health Assistant Professor Leslie Dan Faculty of Pharmacy Disclosures None Thank You Several slides

More information

5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.

5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated. 0 11 Key Messages 1. Ask and document smoking status for all patients. 2. Provide brief advice on quit smoking at every visit to all smokers. 3. Use individual, group and telephone counselling approaches,

More information

Nicotine Replacement and Smoking Cessation: Update on Best Practices

Nicotine Replacement and Smoking Cessation: Update on Best Practices Nicotine Replacement and Smoking Cessation: Update on Best Practices Adrienne Duckworth, MSN, APRN, FNP-C, CTTS Section of Hematology/Oncology WVU Department of Medicine WVU Cancer Institute Objective

More information

Outpatient Tobacco Addiction Treatment Pathway Additional Notes

Outpatient Tobacco Addiction Treatment Pathway Additional Notes Outpatient Tobacco Addiction Treatment Pathway Additional Notes First Line: Varenicline (provide in conjunction with counselling/support, but if such support is refused or is not available, this should

More information

Smoking cessation therapy

Smoking cessation therapy Appendix 1 Smoking cessation therapy Q. Can a dentist prescribe medications for smoking cessation? A. Yes. Dentists are allowed and are encouraged to help patients with smoking cessation by counseling

More information

Effective Treatments for Tobacco Dependence

Effective Treatments for Tobacco Dependence Effective Treatments for Tobacco Dependence Abigail Halperin MD, MPH Director, University of Washington Tobacco Studies Program Ken Wassum Associate Director of Clinical Development and Support Quit for

More information

SMOKING CESSATION. Recommendations 5As Approach to Smoking Cessation. Stages of Change Assisting the Smoker. Contributor Dr. Saifuz Sulami.

SMOKING CESSATION. Recommendations 5As Approach to Smoking Cessation. Stages of Change Assisting the Smoker. Contributor Dr. Saifuz Sulami. SMOKING CESSATION 08 Recommendations 5As Approach to Intervention Stages of Change Assisting the Smoker Pharmacotherapy Contributor Dr. Saifuz Sulami Advisor Dr. Audrey Tan 79 nhg_guideline_14102010_1112.indd

More information

Nicotine Replacement Therapy (NRT).

Nicotine Replacement Therapy (NRT). Nicotine Replacement Therapy (NRT). Information for smokers 1 What is NRT? The aim of Nicotine Replacement Therapy (NRT) is to reduce the withdrawal symptoms associated with nicotine addiction by replacing

More information

Dispensing of Nicotine Replacement Therapy (NRT)

Dispensing of Nicotine Replacement Therapy (NRT) Simcoe Muskoka District Health Unit Print Version Medical Directive Number: Topic: Dispensing of Nicotine Replacement Therapy (NRT) Revised: October 2011 Approved: May 21, 2007 Description Nicotine Replacement

More information

1. Describe the benefits of smoking cessation. 2. List the withdrawal symptoms of quitting smoking. Cessation

1. Describe the benefits of smoking cessation. 2. List the withdrawal symptoms of quitting smoking. Cessation Time to Butt Out Adil Virani, BSc (Pharm), Pharm D, FCSHP Objectives After this presentation, participants should be able to: 1. Describe the benefits of smoking cessation 2. List the withdrawal symptoms

More information

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Smoking Cessation Products LAST REVIEW 5/8/2018 THERAPEUTIC CLASS: Psychiatric Disorders REVIEW HISTORY 5/17, 5/16, 5/15,

More information

Tobacco Cessation: Priority for Health Providers. Acknowledgements. Tobacco Cessation: Secondhand Smoke. Smoke-Free Environment & CA

Tobacco Cessation: Priority for Health Providers. Acknowledgements. Tobacco Cessation: Secondhand Smoke. Smoke-Free Environment & CA Acknowledgements Smoking Cessation Leadership Center http://smokingcessationleadership.ucsf.edu/ Rx for Change http://rxforchange.ucsf.edu/ Tobacco Use and Dependence: 2008 Update http://www.surgeongeneral.gov/tobacco

More information

Introduction to pharmacotherapy

Introduction to pharmacotherapy Introduction to pharmacotherapy Dr. Shamim Jubayer. Research Fellow Dept. Epidemiology and Research National Heart Foundation Hospital And research Institute Effective tobacco cessation medications The

More information

IMPORTANT POINTS ABOUT MEDICATIONS

IMPORTANT POINTS ABOUT MEDICATIONS IMPORTANT POINTS ABOUT MEDICATIONS The U.S. Food & Drug Administration (FDA) advises that there are significant health benefits to quitting smoking. The health benefits of quitting smoking include a reduction

More information

Brief Intervention for Smoking Cessation. National Training Programme

Brief Intervention for Smoking Cessation. National Training Programme Brief Intervention for Smoking Cessation National Training Programme Introduction Monitor tobacco use and prevention policies Protect people from tobacco smoke Offer help to quit tobacco use Warn about

More information

Wanting to Get Pregnant

Wanting to Get Pregnant Continuing Medical Education COPD Case Presentation LEARNING OBJECTIVES Those completing this activity will receive information that should allow them to Assist a patient in developing a quit plan; Advise

More information

PHARMACOTHERAPY OF SMOKING CESSATION

PHARMACOTHERAPY OF SMOKING CESSATION PHARMACOTHERAPY OF SMOKING CESSATION Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure

More information

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD Smoking Cessation A Clinicians Perspective Jeff Wilson, MD Overview Tobacco control what we have accomplished and the road ahead Role of the health care professional Using pharmacotherapy Electronic cigarettes

More information

NYSMPEP Smoking Cessation Guidance: Key Message 3

NYSMPEP Smoking Cessation Guidance: Key Message 3 NYSMPEP Smoking Cessation Guidance: Key Message 3 Key Message 3: All smokers trying to quit should be offered medication (except when contraindicated or for specific populations). The Agency for Healthcare

More information

3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine

3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine How can there be a warning regarding concomitant use of varenicline with nicotine replacement therapy yet patients can be on varenicline and smoke concurrently? April 20, 2017 The United States (US) Preventive

More information

Pharmacotherapy for Tobacco Dependence Treatment

Pharmacotherapy for Tobacco Dependence Treatment Pharmacotherapy for Tobacco Dependence Treatment Nancy Rigotti, MD Professor of Medicine, Harvard Medical School Director, Tobacco Research and Treatment Center, Massachusetts General Hospital nrigotti@partners.org

More information

Tobacco Use Dependence and Approaches to Treatment

Tobacco Use Dependence and Approaches to Treatment University of Kentucky UKnowledge Nursing Presentations College of Nursing 11-2011 Tobacco Use Dependence and Approaches to Treatment Audrey Darville University of Kentucky, audrey.darville@uky.edu Chizimuzo

More information

Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking

Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking Getting Ready to Quit Course Creating Success! THINK ABOUT Process of Changing an Addiction Your Pros and Cons of Smoking and Quitting

More information

Pharmacotherapy for Treating Tobacco Dependence

Pharmacotherapy for Treating Tobacco Dependence Pharmacotherapy for Treating Tobacco Dependence Sheila K. Stevens, MSW Education Coordinator Nicotine Dependence Center 2013 MFMER slide-1 Rationale for Pharmacological Therapy Success rate doubles Manage

More information

Helping People Quit Tobacco

Helping People Quit Tobacco Helping People Quit Tobacco Peter Selby MBBS, CCFP, MHSc, ASAM Associate Professor, University of Toronto Clinical Director, Addictions Program, CAMH Principal Investigator, OTRU Disclosures! Grants/research

More information

Time to Butt Out. Adil Virani, BSc (Pharm), Pharm D, FCSHP

Time to Butt Out. Adil Virani, BSc (Pharm), Pharm D, FCSHP Time to Butt Out Adil Virani, BSc (Pharm), Pharm D, FCSHP Objectives After this presentation, participants should be able to: 1. Describe the benefits of smoking cessation 2. List the withdrawal symptoms

More information

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Learning Objectives TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of

More information

HIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA

HIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA HIV and Aging Making Tobacco Cessation a Priority in HIV/AIDS Services June 27, 2008 Amanda Brown, MPH Ruth Tripp, MPH, RN Objectives To explore existing knowledge of the HIV and smoking connection. To

More information

Smoking and Nicotine Replacement Therapy (NRT) Lec:5

Smoking and Nicotine Replacement Therapy (NRT) Lec:5 Smoking and Nicotine Replacement Therapy (NRT) Lec:5 Tobacco use remains the single largest preventable cause of mortality. Cigarette smoke is a complex mixture of an estimated 4800 compounds. Approximately

More information

Ready to give up. Booklet 3

Ready to give up. Booklet 3 Ready to give up Booklet 3 This booklet is written for people who have decided that they want to stop smoking. You can use this booklet on its own or go through it with the person who gave it to you. You

More information

Medication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019

Medication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019 Medication Management to Aid in Smoking Cessation Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019 1 Learning Objectives: Review the prevalence of tobacco use. Describe tools

More information

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of Pharmacy Learning

More information

The 5A's are practice guidelines on tobacco use prevention and cessation treatment (4):

The 5A's are practice guidelines on tobacco use prevention and cessation treatment (4): Smoking Cessation Module Tobacco use is the single greatest preventable cause of chronic diseases and premature deaths worldwide. The Canadian Cancer Society reports that tobacco product use is responsible

More information

Chantix Label Update 2018

Chantix Label Update 2018 Chantix Label Update 2018 Chantix (varenicline) Prescribing Information Chantix Prescribing Info URL and Disclaimer Please refer to the full Prescribing Information on important treatment considerations

More information

St. Joseph s Health PROVIDER BRIEF. Tobacco Dependence Treatment Guidelines Perinatal and Postpartum Women

St. Joseph s Health PROVIDER BRIEF. Tobacco Dependence Treatment Guidelines Perinatal and Postpartum Women St. Joseph s Health PROVIDER BRIEF Tobacco Dependence Treatment Guidelines Perinatal and Postpartum Women Quitting smoking is perhaps the most important action a pregnant woman can do to ensure the health

More information

Nicotine Replacement Therapy, Zyban and Champix. Name of presentation

Nicotine Replacement Therapy, Zyban and Champix. Name of presentation Nicotine Replacement Therapy, Zyban and Champix Nicotine Replacement Therapy (NRT) - Rationale for use Nicotine is highly addictive and causes unpleasant withdrawal symptoms which often undermine a quit

More information

Tobacco & Nicotine: Addiction and Treatment

Tobacco & Nicotine: Addiction and Treatment Tobacco & Nicotine: Addiction and Treatment Tim McAfee, MD, MPH Chief Medical Officer - Free & Clear 206-876-2551 - tim.mcafee@freeclear.com Affiliate Assistant Professor, University of Washington, School

More information

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services SMOKING CESSATION Introduction NICE recommends that Nicotine Replacement Therapy (NRT), bupropion [Zyban ] and

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Derbyshire Formulary for Nicotine Replacement Therapy (NRT) 1. Supporting Smokers to stop smoking The most effective method to quit smoking is by quitting

More information

Smoking Cessation: Good News at Last!

Smoking Cessation: Good News at Last! Smoking Cessation: Good News at Last! Andrew L. Pipe, CM, MD The Minto Prevention & Rehabilitation Centre University of Ottawa Heart Institute Ottawa, Ontario. Canada apipe@ottawaheart.ca Declaration of

More information

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization

More information

How best to get your patients to stop smoking. Dr Alex Bobak GP and GPSI in Smoking Cessation Wandsworth, London

How best to get your patients to stop smoking. Dr Alex Bobak GP and GPSI in Smoking Cessation Wandsworth, London How best to get your patients to stop smoking Dr Alex Bobak GP and GPSI in Smoking Cessation Wandsworth, London 1 2 Smoking can cause at least 14 different types of cancer 3 Smokers want to stop All smokers

More information

Tobacco Basics and Brief Cessation Interventions. Prepared by: Margie Kvern, RN, MN Diane Mee, RN, BN October 2014

Tobacco Basics and Brief Cessation Interventions. Prepared by: Margie Kvern, RN, MN Diane Mee, RN, BN October 2014 Tobacco Basics and Brief Cessation Interventions Prepared by: Margie Kvern, RN, MN Diane Mee, RN, BN October 2014 Outline Tobacco Basics WRHA Clinical Practice Guideline for Management of Tobacco Use and

More information

Smoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service

Smoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service Smoke-free Hospitals Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service Today s Subjects 5A s and Clinician Training and Use with the Hospitalized Patient NRT use in

More information

Cessation Medicine Reference Guide Table of Contents

Cessation Medicine Reference Guide Table of Contents Cessation Medicine Reference Guide Table of Contents 1. Patch 2. Nicotine Gum 3. Nicotine Lozenge 4. Inhaler 5. Nasal Spray 6. Bupropion SR (Zyban) 7. Chantix (Varenicline) Patch Typical course of therapy

More information

Varenicline and Other Pharmacotherapies for Tobacco Dependence

Varenicline and Other Pharmacotherapies for Tobacco Dependence Varenicline and Other Pharmacotherapies for Tobacco Dependence J. Taylor Hays, M.D. Associate Director Nicotine Dependence Center Mayo Clinic 2012 MFMER slide-1 Learning Objectives Understand the mechanism

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.CPA.113 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Quitting is all about finding what works for you.

Quitting is all about finding what works for you. Quitting is all about finding what works for you. Your guide to finding the right support 02 Smokefree Your way Well done you I can do it! Smokefree provides advice, support and encouragement to help people

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Policy: Smoking Cessation Products Reference Number: TCHP.PHAR.18002 Effective Date: 01.01.19 Last Review Date: 10.12.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the

More information

EMERGING ISSUES IN SMOKING CESSATION

EMERGING ISSUES IN SMOKING CESSATION EMERGING ISSUES IN SMOKING CESSATION Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe, CM, MD University

More information

Tobacco Cessation The Role of the Dentist/Oral Medicinist

Tobacco Cessation The Role of the Dentist/Oral Medicinist Tobacco Cessation The Role of the Dentist/Oral Medicinist Jennifer Frustino, DDS PhD Oral Oncology & Maxillofacial Prosthetics Erie County Medical Center Buffalo, NY Statement of Disclosure I have no actual

More information

Background. Abstinence rates associated with varenicline

Background. Abstinence rates associated with varenicline What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background

More information

Page 1 of 7 INITIAL EVALUATION MANAGEMENT. STATUS Yes. See page 2. Refer patient to a tobacco treatment program 3 (preferred) Patient interested?

Page 1 of 7 INITIAL EVALUATION MANAGEMENT. STATUS Yes. See page 2. Refer patient to a tobacco treatment program 3 (preferred) Patient interested? Page 1 of 7 INITIAL EVALUATION Screen current tobacco use status Has patient smoked more than 100 cigarettes in lifetime? Has patient smoked or used tobacco in the last 12 months? STATUS Within the last

More information

Phil Mohler, M.D Crossroads Blvd P.O. Box Grand Junction, CO July 2016

Phil Mohler, M.D Crossroads Blvd P.O. Box Grand Junction, CO July 2016 Phil Mohler, M.D. phil.mohler@rmhp.org 2775 Crossroads Blvd P.O. Box 10600 Grand Junction, CO 81502-5600 Avoid these expensive me-too drugs: Intermezzo Vimovo Livalo Pristiq Viibyrd Edarbi Daliresp July

More information

SECTION 17: NICOTINE REPLACEMENT. Formulary and Prescribing Guidelines

SECTION 17: NICOTINE REPLACEMENT. Formulary and Prescribing Guidelines SECTION 17: NICOTINE REPLACEMENT Formulary and Prescribing Guidelines 17.1 Introduction These guidelines should be used in conjunction with EPUT No Smoking Policy (HRP20) for service users who are 12 years

More information

Over the Road Truck Driver Who Smokes

Over the Road Truck Driver Who Smokes Continuing Medical Education Case Presentation 1 CME Credit Physicians Physician Assistants Nurse Practitioners Over the Road Truck Driver Who Smokes RELEASE & REVIEW DATE This activity was last reviewed

More information

Tobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare

Tobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare Tobacco Cessation: Best Practices in Cancer Treatment Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare Objectives 1. Describe the current state of tobacco use treatment

More information

Counseling the Tobacco Dependent Patient. Gretchen Whitby, CNP The Lung Center

Counseling the Tobacco Dependent Patient. Gretchen Whitby, CNP The Lung Center Counseling the Tobacco Dependent Patient Gretchen Whitby, CNP The Lung Center http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf Tobacco Dependence Tobacco dependence is a chronic disease

More information

Title: Varenicline for Smoking Cessation. Date: June 4, Context and policy issues:

Title: Varenicline for Smoking Cessation. Date: June 4, Context and policy issues: Title: Varenicline for Smoking Cessation Date: June 4, 2007 Context and policy issues: The prevalence of smoking in Canada continues to drop, according to the 2005 Canadian Tobacco Use Monitoring Survey.

More information

Smokeless Tobacco Cessation: Review of the evidence. Raymond Boyle, PhD Tobacco Summit 2007 MDQuit.org

Smokeless Tobacco Cessation: Review of the evidence. Raymond Boyle, PhD Tobacco Summit 2007 MDQuit.org Smokeless Tobacco Cessation: Review of the evidence Raymond Boyle, PhD Tobacco Summit 2007 MDQuit.org Previous Reviews of ST evidence Hatsukami and Boyle (1997) Evidence base is limited by small sample

More information

Fast Facts. Morbidity and Mortality (Related to Tobacco Use)

Fast Facts. Morbidity and Mortality (Related to Tobacco Use) Fast Facts Morbidity and Mortality (Related to Tobacco Use) Tobacco and Disease Tobacco use causes o Cancer o Heart disease o Lung diseases (including emphysema, bronchitis, and chronic airway obstruction)

More information

Chantix (Varenicline) and Risk of Cardiovascular Events

Chantix (Varenicline) and Risk of Cardiovascular Events PL Detail-Document #270803 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER August 2011 Chantix (Varenicline)

More information

Update on Medications for Tobacco Cessation

Update on Medications for Tobacco Cessation Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction

More information

Adolescents and Tobacco Cessation

Adolescents and Tobacco Cessation Adolescents and Tobacco Cessation Jonathan D. Klein, MD, MPH American Academy of Pediatrics Julius B. Richmond Center and the University of Rochester Rochester, NY Goal To review current evidence and perspectives

More information

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org OVERVIEW The challenge for

More information

Smoking Cessation and the Pharmacist

Smoking Cessation and the Pharmacist Smoking Cessation and the Pharmacist Jennifer Roberts Assistant Director, Research Pharmacy 1 Objectives Review smoking cessation medication use, based on public health guidelines, as well as contraindications

More information

Essentials of Smoking Cessation (2017)

Essentials of Smoking Cessation (2017) Essentials of Smoking Cessation (2017) Dr Alex Bobak Smoking the size of the problem: Biggest preventable cause of death and disease bar none >50% of long term smokers die prematurely from smoking related

More information

Smoking Cessation Services Guidance

Smoking Cessation Services Guidance Smoking Cessation Services Guidance Alabama Medicaid Tobacco Treatment Coverage Covered Services/Medication 1. Free tobacco cessation counseling is provided through the Alabama Tobacco Quitline. Refer

More information

MEDICAL DIRECTIVE Title: Administration of Nicotine Replacement Therapy by Health Professionals at Pinewood Centre of Lakeridge Health

MEDICAL DIRECTIVE Title: Administration of Nicotine Replacement Therapy by Health Professionals at Pinewood Centre of Lakeridge Health Approved by/date: Medical Advisory Comm. Mar 25, 2014 Authorizing physician(s)/nurse practitioner Dr Eli Sagi, Chief of Psychiatry, Medical Director, Mental Health and Pinewood Centre Dr. Ihab Sorial,

More information

Breaking the Chains of Nicotine Dependence - A Breakthrough Approach

Breaking the Chains of Nicotine Dependence - A Breakthrough Approach Breaking the Chains of Nicotine Dependence - A Breakthrough Approach Dr Rob Young Senior Lecturer & Consultant Physician Auckland Hospital, New Zealand Smoking Cessation in 2001 Smoking contributes to

More information

Health Professional Manual

Health Professional Manual Health Professional Manual Session: Smoking Cessation Smoking and COPD Strategies for quitting smoking Adapted from the Living Well with COPD program (2nd edition), Montreal Chest Institute, Canada SESSION

More information

SMART STEPS towards a tobacco-free life

SMART STEPS towards a tobacco-free life SMART STEPS towards a tobacco-free life Ready to Quit Smoking? You decide when. We ll show you how. Smart steps... Ready to Put Tobacco Behind You? Congratulations on deciding to quit! Quitting tobacco

More information

UPDATE TREATMENT OF TOBACCO USE DISORDERS

UPDATE TREATMENT OF TOBACCO USE DISORDERS Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences UPDATE TREATMENT OF TOBACCO USE DISORDERS MARK DUNCAN MD UNIVERSITY OF WASHINGTON OBJECTIVES 1. Remind everyone

More information

Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence

Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence Nancy Rigotti, MD Tobacco Research & Treatment Center, General Medicine Division, Massachusetts General Hospital, Harvard

More information

Keywords: tobacco, cigarette smoke, nicotine, dopamine, smoking cessation, acethylcholine, varenicline (champix )

Keywords: tobacco, cigarette smoke, nicotine, dopamine, smoking cessation, acethylcholine, varenicline (champix ) Review Article and Clinical Experience: ENICLINE (CHAMPIX ) : A BREAKTHROUGH FOR SMOKING CESSATION TREATMENT (An α4ß2 Nicotinic Acethylcholine Receptor Partial Agonist) Askandar Tjokroprawiro Diabetes

More information

Month/Year of Review: March 2014 Date of Last Review: April 2012

Month/Year of Review: March 2014 Date of Last Review: April 2012 Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Copyright 2012 Oregon State University. All Rights

More information

Formulary and Prescribing Guidelines

Formulary and Prescribing Guidelines Formulary and Prescribing Guidelines SECTION 17: NICOTINE REPLACEMENT THERAPY 17.1 Introduction These guidelines should be used in conjunction with SEPT No Smoking Policy (HRP20) and for service users

More information

Addressing Tobacco Use in Iowa

Addressing Tobacco Use in Iowa Addressing Tobacco Use in Iowa A BRIEF TOBACCO INTERVENTION FOR HEALTHCARE PROVIDERS Lorene Mein Beth Turner Alyssa Reichelt DNP, ARNP, FNP-BC MA, CHES MA Mercy Clinics American Lung Association American

More information

HIV and Cardiovascular Risk The Ottawa HIV Quit Smoking Study

HIV and Cardiovascular Risk The Ottawa HIV Quit Smoking Study HIV and Cardiovascular Risk The Ottawa HIV Quit Smoking Study Louise Balfour PhD Paul MacPherson PhD, MD, FRCPC Division of Infectious Diseases Ottawa Hospital University of Ottawa HIV and Cardiovascular

More information

21 INSTRUCTOR GUIDELINES

21 INSTRUCTOR GUIDELINES STAGE: Ready to Quit Ms. Crosby is a 32-year-old woman who recently began attending a worksite group program for smoking cessation. Her group has set a quit date for one week from today, and she would

More information

Tobacco treatment for people with serious mental illness (SMI)

Tobacco treatment for people with serious mental illness (SMI) Tobacco treatment for people with serious mental illness (SMI) An opportunity to close the mortality gap Massachusetts Mental Health Center 1 National Resource Center for Academic Detailing A compelling

More information

Treating Tobacco Use:

Treating Tobacco Use: Treating Tobacco Use: Optimizing for the Best Outcomes Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org Primary

More information

TREATMENT INTERVENTIONS

TREATMENT INTERVENTIONS SMOKING CESSATION TREATMENT INTERVENTIONS Smoking and Health Tobacco is the single most preventable cause of death in the world today. kills more than five million people By 2030, the death toll will exceed

More information

Smoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation

Smoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation Smoking Cessation MariBeth Kuntz, PA-C Duke Center for Smoking Cessation Objectives Tobacco use at population level Tobacco use and control around the world What works for managing tobacco use Common myths

More information

TRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks

TRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks TRENDS IN TOBACCO And What Employers Can Do to Support Cessation Katy Tombaugh, Certified Tobacco Treatment Specialist Founder & CEO, Wellness Collective LEARNING OBJECTIVES Understand the types of tobacco

More information

SMOKING CESSATION IS HARD

SMOKING CESSATION IS HARD POWER TO BREAK THE HOLD OF NICOTINE ADDICTION 1 SMOKING CESSATION IS HARD Most smokers try to quit 5-7 times before they are successful. 2 Why is it so hard to quit? Typical withdrawal symptoms from stopping

More information

Tuberculosis and Tobacco

Tuberculosis and Tobacco ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᔨᒃᑯᑦ Department of Health Munaqhiliqiyitkut Ministère de la Santé Tuberculosis and Tobacco Overlapping Epidemics in Nunavut Brought to you by Tuberculosis (TB) Program Educates and supports

More information

After the Last Cigarette

After the Last Cigarette After the Last Cigarette Treatment Options for Quitting Tobacco By Susan Kahler, MBA, CTTS Risks from Smoking The Highly Engineered Product Nicotine Delivered by Inhalation Characteristics of Nicotine

More information

Legacy Emanuel Medical Center Nicotine Withdrawal Prevention Protocol (NicWiPP) Provider Education

Legacy Emanuel Medical Center Nicotine Withdrawal Prevention Protocol (NicWiPP) Provider Education Legacy Emanuel Medical Center Nicotine Withdrawal Prevention Protocol (NicWiPP) Provider Education Legacy Health Tobacco Program Medical Director: Charles J. Bentz MD, FACP Tobacco Treatment Specialist:

More information

A Guide to Help You Reduce and Stop Using Tobacco

A Guide to Help You Reduce and Stop Using Tobacco Let s Talk Tobacco A Guide to Help You Reduce and Stop Using Tobacco Congratulations for taking this first step towards a healthier you! 1-866-710-QUIT (7848) albertaquits.ca It can be hard to stop using

More information

9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives

9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives The Smoking Gun: for Smoking Cessation in Patients with Mental Health Disorders BRENDON HOGAN, PHARMD PGY2 PSYCHIATRIC PHARMACY RESIDENT CTVHCS, TEMPLE, TX 09/23/2016 I would feel comfortable dispensing/prescribing

More information

Tobacco Cessation For Providers. Betty Murphy Health Promotion Program Naval Hospital Rota

Tobacco Cessation For Providers. Betty Murphy Health Promotion Program Naval Hospital Rota Tobacco Cessation For Providers Betty Murphy Health Promotion Program Naval Hospital Rota Tobacco Statistics Strategies for Implementation Stages of Change Pharmacotherapy Tobacco Use Statistics 70% of

More information